We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Darden Restaurants
DRI
$23.4B
| $937K | 0.01% |
7,710
-31,290
| -80% | -$3.43M |
|
677
CACI
CACI
$11B
| $936K | 0.01% |
+5,140
| New | +$876K |
|
678
Lexicon Pharmaceuticals
LXRX
$991M
| $933K | 0.01% |
167,765
-79,325
| -32% | -$482K |
|
679
First Financial Corp
THFF
$924M
| $926K | 0.01% |
22,047
+900
| +4% | +$38.2K |
|
|
LBAI
680
DELISTED
Lakeland Bancorp Inc
LBAI
| $923K | 0.01% |
61,811
-8,000
| -11% | -$127K |
|
|
CTRL
681
DELISTED
Control4 Corporation
CTRL
| $915K | 0.01% |
54,029
+1,549
| +3% | +$27.9K |
|
682
Air Products & Chemicals
APD
$65.2B
| $911K | 0.01% |
4,770
-19,740
| -81% | -$3.4M |
|
683
Oracle
ORCL
$345B
| $910K | 0.01% |
16,940
-11,550
| -41% | -$588K |
|
|
FPRX
684
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $910K | 0.01% |
67,947
+13,500
| +25% | +$154K |
|
|
ODT
685
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $887K | 0.01% |
+40,117
| New | +$701K |
|
686
Peapack-Gladstone Financial
PGC
$833M
| $884K | 0.01% |
33,724
+1,370
| +4% | +$37.6K |
|
687
Liberty Global Class A
LBTYA
$3.35B
| $873K | 0.01% |
+35,047
| New | +$857K |
|
688
Procter & Gamble
PG
$346B
| $872K | 0.01% |
8,380
-610
| -7% | -$59.4K |
|
689
Metropolitan Bank Holding Corp
MCB
$1.13B
| $871K | 0.01% |
25,043
+200
| +0.8% | +$7.15K |
|
|
ECHO
690
EchoStar
ECHO
$25.1B
| $869K | 0.01% |
+29,419
| New | +$927K |
|
|
NTGN
691
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $869K | 0.01% |
134,593
+79,639
| +145% | +$417K |
|
692
Commercial Vehicle Group
CVGI
$154M
| $867K | 0.01% |
113,009
+52,700
| +87% | +$396K |
|
|
XLNX
693
DELISTED
Xilinx Inc
XLNX
| $865K | 0.01% |
6,820
-297,390
| -98% | -$33.4M |
|
|
NLSN
694
DELISTED
Nielsen Holdings plc
NLSN
| $862K | 0.01% |
+36,400
| New | +$942K |
|
695
TD Synnex
SNX
$19.6B
| $859K | 0.01% |
18,018
-21,680
| -55% | -$1.02M |
|
696
Ameris Bancorp
ABCB
$5.77B
| $854K | 0.01% |
+24,870
| New | +$925K |
|
697
Exelon
EXC
$48.2B
| $848K | 0.01% |
+23,722
| New | +$808K |
|
|
SPTN
698
DELISTED
SpartanNash
SPTN
| $847K | 0.01% |
+53,400
| New | +$1.02M |
|
699
Argan
AGX
$7.61B
| $844K | 0.01% |
16,891
-89,675
| -84% | -$4.04M |
|
700
E.W. Scripps
SSP
$271M
| $835K | 0.01% |
+39,782
| New | +$791K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.